Tan Y, Matsuzaki J, Saito Y, Suzuki H
Genes Environ. 2025; 47(1):5.
PMID: 40045434
PMC: 11881338.
DOI: 10.1186/s41021-025-00328-w.
Lee S, Oh H
Sci Rep. 2024; 14(1):30932.
PMID: 39730741
PMC: 11680954.
DOI: 10.1038/s41598-024-81764-6.
Corallo S, Lasagna A, Filippi B, Alaimo D, Tortorella A, Serra F
Pathogens. 2024; 13(9).
PMID: 39338919
PMC: 11435077.
DOI: 10.3390/pathogens13090728.
Yang M
Front Oncol. 2024; 14:1402483.
PMID: 38835386
PMC: 11148328.
DOI: 10.3389/fonc.2024.1402483.
Grantham T, Ramachandran R, Parvataneni S, Budh D, Gollapalli S, Gaduputi V
J Community Hosp Intern Med Perspect. 2024; 13(6):100-106.
PMID: 38596548
PMC: 11000854.
DOI: 10.55729/2000-9666.1252.
Pathogenesis and therapeutic implications of EBV-associated epithelial cancers.
Low Y, Loh C, Peh D, Chu A, Han S, Toh H
Front Oncol. 2023; 13:1202117.
PMID: 37901329
PMC: 10600384.
DOI: 10.3389/fonc.2023.1202117.
Utility of clinical metagenomics in diagnosing malignancies in a cohort of patients with Epstein-Barr virus positivity.
Song J, Zhu K, Wang X, Yang Q, Yu S, Zhang Y
Front Cell Infect Microbiol. 2023; 13:1211732.
PMID: 37674580
PMC: 10477599.
DOI: 10.3389/fcimb.2023.1211732.
Does Epstein-Barr virus-positive gastric cancer establish a significant relationship with the multiple genes related to gastric carcinogenesis?.
Seo J, Park K, Chin H, Jun K
PLoS One. 2023; 18(6):e0283366.
PMID: 37285389
PMC: 10246845.
DOI: 10.1371/journal.pone.0283366.
Characterization of a new CCCTC-binding factor binding site as a dual regulator of Epstein-Barr virus latent infection.
Lee S, Kim K, Cho M, Huh S, An S, Seo D
PLoS Pathog. 2023; 19(1):e1011078.
PMID: 36696451
PMC: 9876287.
DOI: 10.1371/journal.ppat.1011078.
Circulating Epstein-Barr virus DNA associated with hepatic impairment and its diagnostic and prognostic role in patients with gastric cancer.
He H, Han R, Xu B, Huang C, Li M, He C
Front Med (Lausanne). 2022; 9:1028033.
PMID: 36275793
PMC: 9583533.
DOI: 10.3389/fmed.2022.1028033.
High Frequency of Epstein-Barr Virus and Absence of Papillomavirus in Breast Cancer Patients from Brazilian Northeast.
Oliveira E, Ferreira M, Rahal P, Castelo Branco M, Rabenhorst S
Asian Pac J Cancer Prev. 2022; 23(7):2351-2359.
PMID: 35901341
PMC: 9727371.
DOI: 10.31557/APJCP.2022.23.7.2351.
and Epstein-Barr Virus Co-Infection in Polish Patients with Gastric Cancer - A Pilot Study.
Dzikowiec M, Lik P, Kiszalkiewicz J, Kuczynska A, Mordalski M, Nejc D
Pol J Microbiol. 2022; 71(1):123-129.
PMID: 35635161
PMC: 9152908.
DOI: 10.33073/pjm-2022-004.
Gastric Cancer and Viruses: A Fine Line between Friend or Foe.
Firoz A, Ali H, Rehman S, Rather I
Vaccines (Basel). 2022; 10(4).
PMID: 35455349
PMC: 9025827.
DOI: 10.3390/vaccines10040600.
Association of oral Epstein-Barr virus with periodontal health in Japanese adults.
Su C, Shigeishi H, Murodumi H, Sugiyama M, Ohta K, Takemoto T
Exp Ther Med. 2021; 22(1):767.
PMID: 34055066
PMC: 8145525.
DOI: 10.3892/etm.2021.10199.
Epstein-Barr Virus Infection in the Development of Neurological Disorders.
Soldan S, Lieberman P
Drug Discov Today Dis Models. 2021; 32(Pt A):35-52.
PMID: 33897799
PMC: 8059607.
DOI: 10.1016/j.ddmod.2020.01.001.
The Double-Edged Sword Role of Viruses in Gastric Cancer.
Niedzwiedzka-Rystwej P, Grywalska E, Hrynkiewicz R, Wolacewicz M, Becht R, Rolinski J
Cancers (Basel). 2020; 12(6).
PMID: 32599870
PMC: 7352989.
DOI: 10.3390/cancers12061680.
Postoperative outcomes of gastric carcinoma with lymphoid stroma.
Iwasaki K, Suda T, Takano Y, Ohno Y, Yamada E, Okazaki N
World J Surg Oncol. 2020; 18(1):102.
PMID: 32438924
PMC: 7243312.
DOI: 10.1186/s12957-020-01878-9.
Thirty years of Epstein-Barr virus-associated gastric carcinoma.
Fukayama M, Abe H, Kunita A, Shinozaki-Ushiku A, Matsusaka K, Ushiku T
Virchows Arch. 2019; 476(3):353-365.
PMID: 31836926
DOI: 10.1007/s00428-019-02724-4.
Establishment of a Screening Method for Epstein-Barr Virus-Associated Gastric Carcinoma by Droplet Digital PCR.
Shuto T, Nishikawa J, Shimokuri K, Yanagi A, Takagi T, Takagi F
Microorganisms. 2019; 7(12).
PMID: 31795435
PMC: 6956032.
DOI: 10.3390/microorganisms7120628.
An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity.
Wells M, Jacobson S, Levine P
Infect Agent Cancer. 2019; 14:31.
PMID: 31709003
PMC: 6833260.
DOI: 10.1186/s13027-019-0248-3.